Scientific organizations recently called for a 10-year ban on human germline editing. But will we ever be ready? And how ...

Bootstrap Bio has hired a chief science officer, opened a lab and sought seed funding to edit human cells that can be passed ...

A new study highlights a historic step in personalized medicine, utilizing CRISPR gene-editing technology for a ...

Researchers have uncovered how losing the autism-linked gene PTEN in a specific set of inhibitory neurons reshapes brain circuits tied to fear and anxiety.

During a live event, Saby George, MD, and participants discussed tolerability concerns in patients with recurrent renal cell ...

PepGen leverages a graph-based approach to improve the detection of hidden protein variants in a computationally efficient ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit writes about the key takeaways from the ASCO 2025 Annual ...

Belzutifan is a hypoxia-inducible factor-2α inhibitor that is US FDA approved for the treatment of VHL disease-associated renal cell carcinoma (RCC), CNS hemangioblastomas, or pancreatic ...

Patients with BRCA-mutant breast cancer had a significantly higher risk of breast implant-associated anaplastic large-cell ...

Families of those who have sickle cell disease in the Philadelphia area are pushing for more research and a cure.